Clinical Trial Update: A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma [Phase 3]

View source ↗

Summary

Phase 3 randomized trial in recruitment evaluating Belzupacap Sarotalocan (AU-011) versus sham control for primary indeterminate lesions or small choroidal mela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Melanoma
• Ocular Melanoma
• Uveal Melanoma

Drugs mentioned

• AU-011 (Belzupacap Sarotalocan) (Belzupacap Sarotalocan)

Snippet

Sponsor: Aura Biosciences | Conditions: Choroidal Melanoma, Indeterminate Lesions | Phase 3 | Status: RECRUITING